1. Home
  2. HUSA vs MRKR Comparison

HUSA vs MRKR Comparison

Compare HUSA & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUSA
  • MRKR
  • Stock Information
  • Founded
  • HUSA N/A
  • MRKR N/A
  • Country
  • HUSA United States
  • MRKR United States
  • Employees
  • HUSA N/A
  • MRKR N/A
  • Industry
  • HUSA Oil & Gas Production
  • MRKR Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUSA Energy
  • MRKR Health Care
  • Exchange
  • HUSA Nasdaq
  • MRKR Nasdaq
  • Market Cap
  • HUSA 21.3M
  • MRKR 19.1M
  • IPO Year
  • HUSA N/A
  • MRKR N/A
  • Fundamental
  • Price
  • HUSA $10.86
  • MRKR $1.56
  • Analyst Decision
  • HUSA
  • MRKR Strong Buy
  • Analyst Count
  • HUSA 0
  • MRKR 3
  • Target Price
  • HUSA N/A
  • MRKR $13.17
  • AVG Volume (30 Days)
  • HUSA 302.6K
  • MRKR 3.4M
  • Earning Date
  • HUSA 08-13-2025
  • MRKR 08-13-2025
  • Dividend Yield
  • HUSA N/A
  • MRKR N/A
  • EPS Growth
  • HUSA N/A
  • MRKR N/A
  • EPS
  • HUSA N/A
  • MRKR N/A
  • Revenue
  • HUSA N/A
  • MRKR $5,696,123.00
  • Revenue This Year
  • HUSA N/A
  • MRKR N/A
  • Revenue Next Year
  • HUSA N/A
  • MRKR $7.16
  • P/E Ratio
  • HUSA N/A
  • MRKR N/A
  • Revenue Growth
  • HUSA N/A
  • MRKR 71.53
  • 52 Week Low
  • HUSA $3.85
  • MRKR $0.95
  • 52 Week High
  • HUSA $32.00
  • MRKR $5.95
  • Technical
  • Relative Strength Index (RSI)
  • HUSA 51.17
  • MRKR 49.21
  • Support Level
  • HUSA $9.90
  • MRKR $1.41
  • Resistance Level
  • HUSA $11.56
  • MRKR $1.65
  • Average True Range (ATR)
  • HUSA 0.96
  • MRKR 0.33
  • MACD
  • HUSA -0.12
  • MRKR -0.02
  • Stochastic Oscillator
  • HUSA 46.67
  • MRKR 5.64

About HUSA Houston American Energy Corporation

Houston American Energy Corp is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its properties, and operations, are in the U.S. Permian Basin, the U.S. Gulf Coast region, particularly Louisiana, and the South American country of Colombia. Geographically, the company currently has operations in two geographical areas, the United States, from where it derives maximum revenue, and Colombia.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: